Successful integration of hepatitis C evaluation and treatment services with methadone maintenance.
about
Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysisHepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factorsEligibility of persons who inject drugs for treatment of hepatitis C virus infection.Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection.Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics.Clinical characteristics and risk behavior as a function of HIV status among heroin users enrolled in methadone treatment in northern TaiwanAssessing the Long-Term Impact of Treating Hepatitis C Virus (HCV)-Infected People Who Inject Drugs in the UK and the Relationship between Treatment Uptake and Efficacy on Future Infections.Behavioral and quality-of-life outcomes in different service models for methadone maintenance treatment in Vietnam.Stability of liver fibrosis among HCV-infected injection drug usersFactors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review.The new paradigm of hepatitis C therapy: integration of oral therapies into best practices.Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antiviralsAccessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers.Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all.Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements.Developing a modified directly observed therapy intervention for hepatitis C treatment in a methadone maintenance program: implications for program replication.A quasi-experimental evaluation of dried blood spot testing through community pharmacies in the Tayside region of Scotland.Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study.Expanding capacity for hepatitis C treatment in the United States: team-based care and use of nonphysician providers.Deaths among people with hepatitis C in New York City, 2000-2011.Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study.Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study.From the bedside to the community: comparative effectiveness, health services, and implementation research.Telementoring with project ECHO: a pilot study in Europe.HIV Serostatus and Having Access to a Physician for Regular Hepatitis C Virus Care Among People Who Inject Drugs.
P2860
Q26822903-2E93702E-813F-48D4-89CD-74C69108D318Q26853671-508540FF-D622-4282-AB18-3CC4C237519CQ30429470-194ACAB9-BFE8-4691-8C60-AB4368F7F4DFQ33853664-C54F6F48-05D8-4AE7-9409-0A45CD3E803CQ34073122-2EAF2F8A-68AB-4688-A4ED-F5626B33FAD0Q34818254-6A95867E-40FA-4FF1-BC7C-702925916477Q35565944-E801FF78-071C-4A99-9692-1E2A25750327Q36530984-60DD1426-E3FC-40FC-9ED1-BD7349B09B7CQ36975862-4C86C26D-426D-46BF-8F1D-DA287EFA9635Q37245420-38CE6689-22E7-493B-9E24-4063FB5D1647Q37455611-EDFEEFBE-D9AB-44AF-8875-039319D7D04BQ37601315-D7582D05-95C3-4823-8057-624E18232B40Q38064495-DC710B60-180E-470D-B8F9-3113FED05DDCQ38123945-82ECAD52-FF5D-4491-A376-80BC88484C62Q38407675-15208619-9722-4639-ACDB-471B8515167FQ39664785-92DF0B04-A9A6-49CC-8147-60233F85AFE7Q40070901-72310C43-93F8-4A35-8F20-2A9FDD6385FFQ40959924-5536B7B5-9AAE-4F16-B2D4-607F5AA30C6AQ41412724-FD796465-9C4D-4D57-A4A1-0772894147ACQ42237379-73250D3F-67D7-4434-901C-D75A30BA017EQ42251464-1266FE62-BCCC-4A4E-9C46-DFE97CE55FA5Q42280287-69B24D38-E81D-4682-9D4D-150C1FEFF3EEQ46608568-EAB8CB35-9AB6-4AD0-A7E4-E43A9BE68C23Q49640064-1A039D25-8861-46BD-BD07-EC6E3A6CEB91Q54239548-3BE7AAAB-078E-4CDB-A286-F1F10AF84AF4
P2860
Successful integration of hepatitis C evaluation and treatment services with methadone maintenance.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Successful integration of hepa ...... es with methadone maintenance.
@ast
Successful integration of hepa ...... es with methadone maintenance.
@en
type
label
Successful integration of hepa ...... es with methadone maintenance.
@ast
Successful integration of hepa ...... es with methadone maintenance.
@en
prefLabel
Successful integration of hepa ...... es with methadone maintenance.
@ast
Successful integration of hepa ...... es with methadone maintenance.
@en
P2093
P2860
P1476
Successful integration of hepa ...... es with methadone maintenance.
@en
P2093
Alain H Litwin
Julia H Arnsten
Kenneth A Harris
P2860
P356
10.1097/ADM.0B013E3181ADD3DE
P577
2010-03-01T00:00:00Z